Clinical Trials Browser

Phase 2 × Cardiotoxicity × Trastuzumab × Clear all

NCT00436566 2022-08-05

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Phase 2 Completed

122 enrolled 22 charts

Breast Neoplasms, Breast Neoplasms, Male, Cardiotoxicity

NCT00377780 2015-09-23

MYOHERTAX

Phase 2 Terminated

Breast Neoplasms, Neoplasm Metastasis, Cardiotoxicity